Skip to content
buyWeak cluster of 2

GABELLI MARIO J bought $1,154 of GRX

director, other at Gabelli Healthcare & WellnessRx Trust. 112 shares at an average of $10.31, traded Nov 27, 2024, filed Dec 2, 2024.

Conviction score
23
Value
$1,154
112 shares
Holdings after
220,872
+0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001271163-24-000072, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 27, 2024POpen-market purchase
Common Shares, Par Value $0.001
+112$10.31$1,154220,872Dec 2, 2024

Related signals

Other insiders at Gabelli Healthcare & WellnessRx Trust and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
32Weakbuy 2GRX
Gabelli Healthcare & WellnessRx Trust
Saba Capital Management, L.P.
owner
$199k20,408
34Weakbuy 2GRX
Gabelli Healthcare & WellnessRx Trust
GABELLI MARIO J
director, other
$41k4,000
40Moderatebuy 2GRX
Gabelli Healthcare & WellnessRx Trust
GABELLI MARIO J
director, other
$33k3,137
45Moderatebuy 2GRX
Gabelli Healthcare & WellnessRx Trust
GABELLI MARIO J
director, other
$83k7,863
15Weakbuy 2GRX
Gabelli Healthcare & WellnessRx Trust
Saba Capital Management, L.P.
owner
$14k1,312
22Weakbuy 2GRX
Gabelli Healthcare & WellnessRx Trust
Saba Capital Management, L.P.
owner
$54k5,153
24Weakbuy 2GRX
Gabelli Healthcare & WellnessRx Trust
Saba Capital Management, L.P.
owner
$91k8,792
28Weakbuy 2GRX
Gabelli Healthcare & WellnessRx Trust
GABELLI MARIO J
director, other
$31k3,000
21Weakbuy 2GRX
Gabelli Healthcare & WellnessRx Trust
Saba Capital Management, L.P.
owner
$44k4,341
22Weakbuy 2GRX
Gabelli Healthcare & WellnessRx Trust
Saba Capital Management, L.P.
owner
$50k4,876

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.